Most patients with rectal cancer — including low rectal cancer — can avoid a permanent colostomy bag through robotic sphincter-preserving surgery. Dr. Vinod T. Gore performs Robotic TME, LAR, and Intersphincteric Resection at Sahyadri Manipal Hospital, Pune.
The rectum is the final 12–15 cm of the large bowel before the anus. Rectal cancer arises from abnormal cells in the rectal wall — usually beginning as a polyp that slowly grows and, over years, becomes cancerous.
Rectal cancer is distinct from colon cancer primarily because of its anatomical location — deep in the narrow pelvis, surrounded by the sphincter muscles, bladder, and pelvic nerves. This makes surgery technically demanding and is why the surgical approach (and the surgeon's experience) has an outsized impact on outcomes.
In India, rectal cancer is among the most common GI cancers — and is increasingly seen in patients under 50. When detected early, the vast majority of rectal cancers are curable. Screening colonoscopy from age 45 — or earlier if symptoms arise — is essential.
Never ignore rectal bleeding or a persistent change in bowel habits. These symptoms require immediate evaluation — early rectal cancer is highly curable.
Staging determines the optimal treatment. MRI pelvis is mandatory for all rectal cancer staging — it defines the tumour relationship to the mesorectal fascia and guides the neoadjuvant therapy decision.
| Stage | Classification | Description | 5-yr Survival |
|---|---|---|---|
Stage I | T1–T2, N0, M0 | Confined to the rectal wall. Surgery alone is usually curative. Excellent prognosis. | 90–95% |
Stage II | T3–T4, N0, M0 | Grown through the rectal wall but not into nearby lymph nodes. Neoadjuvant therapy often recommended. | 75–85% |
Stage III | Any T, N1–N2, M0 | Spread to nearby lymph nodes. Neoadjuvant chemoradiation followed by TME surgery. | 50–75% |
Stage IV | Any T, Any N, M1 | Spread to liver, lungs, or peritoneum. Coordinated systemic therapy + surgery for select patients. | Variable |
Every rectal cancer case follows a structured, evidence-based pathway — with every decision made collaboratively at the MDT tumour board.
Preserving the sphincter muscle and maintaining natural bowel function is a primary surgical goal for every rectal cancer patient at Silver Leaf Clinic. With robotic surgery, Dr. Gore achieves sphincter preservation in the majority of patients — including those with very low rectal tumours.
TME is the single most important technical principle in rectal cancer surgery — removing the entire mesorectal envelope containing the lymph nodes and fatty tissue surrounding the rectum, along the correct embryological plane. Performed robotically, the 3D magnified view and wristed instruments allow precise nerve-sparing dissection deep in the narrow pelvis — protecting bladder control and sexual function. The circumferential resection margin (CRM) — the key quality indicator — is significantly better with robotic TME.
Low Anterior Resection removes the cancerous segment of the rectum while preserving the sphincter muscle. The bowel is joined again with a stapled anastomosis. A temporary loop ileostomy protects the join while it heals — and is typically reversed 2–3 months later.
ISR is the most advanced sphincter-preserving operation — for cancers at the very lowest part of the rectum. The inner sphincter is removed as part of the resection, while the outer sphincter is preserved, maintaining continence. Requires exceptional surgical precision.
APR permanently removes the rectum and sphincter muscles and creates a permanent end colostomy. Reserved for cancers that directly invade the sphincter muscle. Every patient is thoroughly assessed for sphincter preservation before APR is recommended.
Understanding the difference between a temporary and permanent stoma is one of the most important things patients want clarity on. Dr. Gore's team provides detailed counselling before any procedure.
Dedicated stoma counselling is provided before surgery by Dr. Gore's specialist nursing team — covering stoma siting, care at home, diet, clothing, activity, travel, and reversal planning. No patient faces a stoma without full preparation and ongoing support.
In the majority of patients, Dr. Gore achieves sphincter preservation — meaning no permanent bag. Through robotic Low Anterior Resection (LAR) or Intersphincteric Resection (ISR), natural bowel function is preserved. A temporary ileostomy is used to protect the bowel join for 2–3 months and is then reversed. Permanent colostomy (APR) is reserved for tumours that directly invade the sphincter muscle — this applies to a minority of patients and is only recommended after thorough MDT review.
TME is the surgical principle of removing the entire mesorectal package — the fatty envelope containing lymph nodes surrounding the rectum — along the correct anatomical plane. Introduced in the 1980s, TME reduced local recurrence of rectal cancer from over 25% to under 5%. It is now the mandatory standard for all rectal cancer surgery. Robotic TME allows this to be performed with superior nerve-sparing precision compared to open surgery.
The rectum sits deep in the narrow pelvic space — especially in men and obese patients. Open surgery requires a long incision and working with limited visibility at depth. The da Vinci robot's 3D vision and 7-degree-of-freedom instruments are ideally suited to this confined anatomy — enabling nerve-sparing dissection, sphincter preservation, and precise anastomosis that would be technically impossible with other approaches.
Chemoradiation (long course, 5–6 weeks) or short-course radiotherapy is recommended before surgery for Stage II–III rectal cancers. It shrinks the tumour, sterilises lymph nodes, reduces local recurrence after surgery, and can convert some tumours to allow sphincter preservation that wouldn't otherwise be possible. A repeat MRI after chemoradiation confirms how well the tumour responded.
A small proportion of patients who receive chemoradiation achieve a 'complete clinical response' — where the tumour disappears entirely on MRI and endoscopy. These patients can be offered close surveillance ('Watch and Wait') instead of immediate surgery, with surgery reserved if the tumour regrows. This approach avoids the risks of major surgery in selected cases. It requires rigorous long-term follow-up.
With robotic surgery: most patients are mobile within 24 hours, eating on day 2–3, and discharged in 5–7 days. Full recovery is 6–8 weeks. If adjuvant chemotherapy is needed, it begins 4–6 weeks post-operatively. Ileostomy reversal is a shorter procedure performed 2–3 months later, usually with a 2–3 day hospital stay.
Bring your MRI pelvis, CT scan, and biopsy report. Dr. Gore will review everything at the first consultation and give you a clear, honest picture of your options — including every sphincter-preservation possibility.
Consultations at Silver Leaf Clinic, Hadapsar. Robotic surgery performed at Sahyadri Manipal Hospital — Pune's designated Robotic Cancer Surgery Centre of Excellence.